XML 98 R81.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation Plans (Schedule of Weighted-Average Assumptions for Stock Options) (Details)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
2017 [Member] | Performance Shares [Member]    
Risk-free rate(1) [1] 1.60%  
Expected dividends 0.00%  
Expected Avon volatility(2) [2] 61.00%  
Expected average volatility(3) [3] 29.00%  
2017 [Member] | Stock Options [Member]    
Risk-free rate(1) [4] 2.10%  
Expected term(2) [5] 7 years  
Expected Avon volatility(3) [6] 41.00%  
Expected dividends 0.00%  
2016 [Member] | Performance Shares [Member]    
Risk-free rate(1) [1]   1.10%
Expected dividends   0.00%
Expected Avon volatility(2) [2]   56.00%
Expected average volatility(3) [3]   28.00%
2016 [Member] | Stock Options [Member]    
Risk-free rate(1) [4]   1.60%
Expected term(2) [5]   7 years
Expected Avon volatility(3) [6]   39.00%
Expected dividends   0.00%
[1] The risk-free rate was based upon the rate on a zero coupon U.S. Treasury bill, for periods within the three year performance period, in effect at the time of grant.
[2] Expected Avon volatility was based on the weekly historical volatility of our stock price, over a period similar to the three year performance period of the 2017 PRSUs and 2016 PRSUs and the three year service period of the 2015 PRSUs.
[3] Expected average volatility was based on the weekly historical volatility of the stock prices of each member of companies included in the S&P 400 index as of the date of the grant, over a period similar to the three year performance period of the 2017 PRSUs and 2016 PRSUs.
[4] The risk-free rate was based upon the rate on a zero coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of grant.
[5] The expected term of the option was based on the vesting terms of the respective option and a contractual life of 10 years.
[6] Expected Avon volatility was based on the daily historical volatility of our stock price, over a period similar to the expected life of the option.